See the DrugPatentWatch profile for Eloctate
What is Eloctate’s list price, and why does it vary?
Eloctate (efmoroctocog alfa) is an FDA-approved hemophilia A replacement therapy. Pricing can differ by country, pharmacy, insurance coverage, and contract discounts, so there is no single public “one price” that applies to every patient. In practice, the amount a patient pays depends mostly on their insurance plan, deductible status, and prior authorization requirements.
Because you asked specifically about “Eloctate pricing,” the most relevant question is what market you mean (U.S. vs. another country) and whether you want list price (wholesale acquisition style pricing) or out-of-pocket cost.
How much does Eloctate cost in the U.S.?
To quote a number accurately, I need the details that determine the dose and the number of vials used (price is effectively “per unit” and varies with strength and treatment regimen). Eloctate pricing also changes over time due to manufacturer updates and payer negotiations.
If you tell me:
- your country (or ZIP/postal code for the U.S.),
- the vial strength you’re looking for (or your prescribed dose),
- and whether you want list price or expected insurance/copay/coinsurance,
I can narrow to the right figure and explain what drives the total.
What affects Eloctate cost the most (dose, insurance, and authorization)?
For hemophilia factor products, cost drivers typically include:
- Dose size and treatment frequency (prophylaxis vs. on-demand).
- Product strength and vial size used for each infusion.
- Coverage tier and whether the insurer requires a specialty pharmacy.
- Prior authorization and step therapy rules.
Even when two people use the same product, their monthly spend can differ sharply based on their dosing schedule and coverage.
Are there cheaper alternatives to Eloctate (and how prices compare)?
Eloctate is one of several hemophilia A factor VIII products. Prices can differ across:
- other brand-name factor VIII concentrates,
- biosimilars (where available),
- and non-factor therapies (depending on hemophilia A patient eligibility and guideline fit).
If you name the alternative you’re considering, I can compare what typically changes in cost structure (for example, pharmacy benefit vs. buy-and-bill, and authorization requirements).
Can patients reduce what they pay for Eloctate?
Copay assistance and patient support programs sometimes exist for specialty infusion drugs, but eligibility and availability vary by insurance status and geography. The fastest path to a correct answer is to match the program to the patient’s payer situation (commercial insurance, Medicare, Medicaid, uninsured).
If you share whether the patient has commercial insurance, Medicare, Medicaid, or is uninsured, I can tell you what options are usually relevant to that category.
What I need from you to give a real price number
Reply with:
1) Country (and ZIP/postal code if U.S.)
2) Eloctate vial size/strength your prescriber uses (or your prescribed IU per dose)
3) Are you asking for list price or out-of-pocket estimate?
4) Prophylaxis or on-demand?
Then I can give a pricing figure in the format you want (per vial, per month, or per treatment cycle) and explain the key assumptions.